RxDoctor Payments Data

Oksana Williams

Nurse Practitioner · Albuquerque, NMNPI 1316694805

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.3% of the total across 69 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 24.7% of the total. 2025 is the largest year on record at $1,625, more than ten times the $66 reported in 2023. Among nurse practitioner clinicians in NM with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,456in general payments, 2019–2025

Across 69 payments — averaging $35.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$608
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$302
  • Gilead$294
  • Johnson & Johnson$242
  • Phathom Pharmaceuticals, Inc.$203
  • Takeda Pharmaceuticals U.S.A., Inc.$178
  • plus $629 from 10 others

What the payments were for

  • Food & beverage$2,43799%
  • Education$181%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,456 in reported general payments places this provider in the 90th percentile of 624 nurse practitioner providers in New Mexico.

See all nurse practitioner providers in New Mexico

Medicare billing

Part B allowed, 2024
$40,733
Medicare patients
319
Services billed
380

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Famotidine99$1,416
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl76$1,355
Omeprazole71$991
Pantoprazole Sodium37$471
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl24$387
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg12$182
Hydrocortisone11$69

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →